Age–Related Macular Degeneration: References

1. Quillen DA. Common causes of vision loss in elderly patients. Am Fam Physician. 1999;60:99–108.

2. Klein R, Clegg L, Cooper LS, et al. Prevalence of age–related maculopathy in the Atherosclerosis Risk in Communities Study. Arch Ophthalmol. 1999;117:1203–1210.

3. Klein R, Klein BE, Knudtson MD, et al. Prevalence of age–related macular degeneration in 4 racial/ethnic groups in the multi–ethnic study of atherosclerosis. Ophthalmology. 2006;113:373–380.

4. Weih LM, VanNewkirk MR, McCarty CA, Taylor HR. Age–specific causes of bilateral visual impairment. Arch Ophthalmol. 2000;118:264–269.

5. Seddon JM, Willett WC, Speizer FE, Hankinson SE. A prospective study of cigarette smoking and age–related macular degeneration in women. JAMA. 1996;276:1141–1146.

6. Lebuisson DA, Leroy L, Rigal G. Treatment of senile macular degeneration with Ginkgo biloba extract. A preliminary double–blind drug vs. placebo study [In French]. Presse Med. 1986;15:1556–1558.

7. Fies P, Dienel A. Ginkgo extract in impaired vision––treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration [in German]. Wien Med Wochenschr. 2002;152:423–426.

8. Photodynamic therapy of subfoveal choroidal neovascularization in age–related macular degeneration with verteporfin: one–year results of 2 randomized clinical trials––TAP report. Treatment of age–related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol. 1999;117:1329–1345.

9. Seddon JM, Cote J, Davis N, Rosner B. Progression of age–related macular degeneration: association with body mass index, waist circumference, and waist–hip ratio. Arch Ophthalmol. 2003;121:785–792.

10. Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ. Body mass index and the incidence of visually significant age–related maculopathy in men. Arch Ophthalmol. 2001;119:1259–1265.

11. Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age–related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol. 1998;116:583–587.

12. Klein R, Klein BE, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long–term incidence of age–related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 2003;110:1273–1280.

13. Smith W, Mitchell P, Leeder SR. Dietary fat and fish intake and age–related maculopathy. Arch Ophthalmol. 2000;118:401–404.

14. Mares–Perlman JA, Brady WE, Klein R, VandenLangenberg GM, Klein BE, Palta M. Dietary fat and age–related maculopathy. Arch Ophthalmol. 1995;113:743–748.

15. Seddon JM, Cote J, Rosner B. Progression of age–related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol. 2003;121:1728–1737.

16. Cho E, Hung S, Willett WC, et al.  Prospective study of dietary fat and the risk of age–related macular degeneration. Am J Clin Nutr. 2001;73:209–218.

17. Seddon JM, Rosner B, Sperduto RD, et al.  Dietary fat and risk for advanced age–related macular degeneration. Arch Ophthalmol. 2001;119:1191–1199.

18. Ribaya–Mercado JD, Blumberg JB. Lutein and zeaxanthin and their potential roles in disease prevention. J Am Coll Nutr. 2004;23(suppl 6):567S–587S.

19. Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MOM. Factors associated with age–related macular degeneration: an analysis of data from the First National Health and Nutrition Examination Survey. Am J Epidemiol. 1998;128:700–710.

20. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age–related macular degeneration. Eye Disease Case–Control Study Group. JAMA. 1994;272:1413–1420.

21. Cho E, Seddon JM, Rosner B, Willett WC, Hankinson SE. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age–related maculopathy. Arch Ophthalmol. 2004;122:883–892.

22. Age–Related Eye Disease Study Research Group. A randomized, placebo–controlled, clinical trial of high–dose supplementation with vitamins C and E, beta–carotene, and zinc for age–related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417–1436.

23. Miller ER 3rd, Pastor–Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta–analysis: high–dosage vitamin E supplementation may increase all–cause mortality. Ann Intern Med. 2005;142:37–46.

24. Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D. Double–masked, placebo–controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age–related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry. 2004;75:216–230.

25. Olmedilla B, Granado F, Blanco I, Vaquero M. Lutein, but not alpha–tocopherol, supplementation improves visual function in patients with age–related cataracts: a 2–y double–blind, placebo–controlled pilot study. Nutrition 2003;19:21–24.